Latest News
The power behind science-backed supplements
In a market flooded with flashy labels and lofty health promises, choosing the right supplement can feel more like guesswork than wellness. As the $60 billion supplement industry continues to expand, science – not hype – separates what’s truly beneficial from what's...
Pathways Bioscience Founder Featured in Health.com Article
The following is an excerpt from an article from Health.com, which featured Dr. Joe McCord, founder of Pathways Bioscience, on the latest research into luteolin, a key ingredient in PB125. Read more of Dr. McCord’s insights into this powerful compound here. Do you...
More than half-century of research fuels science behind PB125®
In 1969, Dr. Joe McCord and Dr. Irwin Fridovich initiated the field of free radical biology and medicine with the discovery of the enzyme superoxide dismutase (SOD) – a discovery that continues to fuel the work of Pathways Bioscience today. Free radicals are molecules...
Under the lab coat: Meet the scientists behind the revolutionary PB125® supplement
A Legacy of Innovation Our team boasts over a century of combined research and development experience, leading to our belief that the best way to enhance wellness is by empowering the body’s own mechanisms to protect and heal itself. This guiding philosophy is at the...
Pathways Bioscience Celebrates 10-Year Anniversary
The biomedical science company developed the PB125® dietary supplement that regulates a network of hundreds of genes inside cells and supports overall health and wellness Aurora, Colo. (September 3, 2024) Pathways Bioscience LLC, a biomedical science company dedicated...
Pathways Bioscience Announces Publication of Scientific Paper on the Complexity of the Nrf2 Transcription Factor Pathway
The complexity of the Nrf2 pathway reflects its evolutionary importance in biology AURORA, COLORADO, UNITED STATES, February 14, 2023 /EINPresswire.com/ -- Pathways Bioscience LLC, a biomedical sciences company focused on discovering and developing dietary...
Pathways Bioscience Announces Scientific Publication of Collaborative Research on Aging, Nrf2, Muscles, and Mitochondria
Nrf2 activation by PB125® improved mitochondrial respiration and protein synthesis AURORA, COLORADO, UNITED STATES, Dec 9, 2022 /EINPresswire.com/ -- Pathways Bioscience LLC, a biomedical sciences company focused on discovering and developing small...
Pathways Bioscience Announces Issuance of International Patents for Their Nrf2-Activating Dietary Supplements
Patents in Mexico, Peru, Colombia, and Japan cover the Pathways Bioscience PB123 and PB125® products AURORA, COLORADO, UNITED STATES, Oct 12, 2022 /EINPresswire.com/ -- Pathways Bioscience LLC, a biomedical sciences company focused on discovering and...
Pathways Bioscience Announces Issuance of U.S. Patent for Their Nrf2-Activating Dietary Supplements
New U.S. patent covers the Pathways Bioscience PB123 and PB125® products AURORA, COLORADO, UNITED STATES, September 27, 2022 /EINPresswire.com/ -- Pathways Bioscience LLC, a biomedical sciences company focused on discovering and developing small molecule drugs and...
Pathways Bioscience Announces Scientific Publication of Collaborative Research on Helianthemum nummularium Alpine Plant
This plant, which is over-represented in the diets of local ungulates in the Alps, was found to activate the cell protective Nrf2 transcription factor AURORA, COLORADO, UNITED STATES, July 17, 2020 /EINPresswire.com/ -- Pathways Bioscience LLC, a biomedical...